Skip to main content

Ikarian Capital, LLC

SEC CIK
0001778253
Latest filing
Aug 14, 2026

MNPR holding history

Monopar Therapeutics in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MNPR overviewAll 13F holders of MNPRFull Q2 2026 holdings

Shares (Q2 2026)
47,861
Value
$4.43M
% of portfolio
0.7%
Quarters held
3
Since Q4 2024
Holdings of MNPR by Ikarian Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202647,861$4.43M0.7%+47,861NewHolders
Q2 20250$00.0%−5,908−100.0%Sold outHolders
Q1 20255,908$215.1K0.1%00.0%UnchangedHolders
Q4 20245,908$130.0K<0.1%+5,908NewHolders